References
- Cipolla D, Gonda I. Formulation technology to repurpose drugs for inhalation delivery. Drug Discov Today. 2011;8(3–4):123–130. doi:10.1016/j.ddstr.2011.07.001.
- Patton J, Fishburn C, Weers J. The lungs as a portal of entry for systemic drug delivery. Proc Am Thorac Soc. 2004;1:338–344.
- Siekmeier R, Scheuch G. Systemic treatment by inhalation of macromolecules – principles, problems and examples. J Physiol Pharmacol. 2008;59(6):53–79.
- Weers JG, Bell J, Chan HK, et al. Pulmonary formulations: what remains to be done? J Aerosol Med Pulm Drug Deliv. 2010;23(S2):S5–S23.
- Cipolla D, Shekunov B, Blanchard J, et al. Lipid-based carriers for pulmonary products: preclinical development and case studies in humans. Adv Drug Deliv Rev. 2014;75:53–80. doi:10.1016/j.addr.2014.05.001.
- Edwards D, Hanes J, Caponetti G, et al. Large porous particles for pulmonary drug delivery. Science. 1997;276:1868–1871.
- Cipolla D, Johansson E. AERx pulmonary drug delivery systems. In: Rathbone MJ, Hadgraft J, Roberts MS, et al. editors. Modified release drug delivery technology. 2nd ed. New York: Informa Healthcare; 2008. p. 563–571
- Cipolla D, Chan H-K, Schuster J, et al. Personalized medicine: development of inhalation systems tailored to the individual. Ther Deliv. 2010;1(5):667–682.
- Bitonti A, Dumont J. Pulmonary administration of therapeutic proteins using an immunoglobulin transport pathway. Adv Drug Deliv Rev. 2006;58(9–10):1106–1118.
- Wolff R. Safety of inhaled proteins for therapeutic use. J Aerosol Med. 1998;11:197–219.
- Cavaiola TS, Edelman S. Inhaled insulin: a breath of fresh air? A review of inhaled insulin. Clin Ther. 2014;36(8):1275–1289.
- Patton JS, Porter L. Re-thinking inhaled insulin’s role in the global challenge to treat diabetes. In: Dalby RN, Byron PR, Peart J, et al., editors. Respiratory drug delivery Europe 2015. Vol. 2015. River Grove (IL): Davis Healthcare Int’l Publishing; 2013. p. 49–58, 237–242.
- Hickey AJ. Back to the future: inhaled drug products. J Pharm Sci. 2013;102(4):1165–1171.
- Angelo R, Rousseau K, Grant M, et al. Technosphere insulin: defining the role of technosphere particles at the cellular level. J Diabetes Sci Technol. 2009;3:545–554.
- Kim ES, Plosker GL. AFREZZA® (insulin human) inhalation powder: a review in diabetes mellitus. Drugs. 2015;75:1679–1686.
- Cipolla D, Gonda I. Inhaled nicotine replacement therapy. Asian J Pharm Sci. 2015;10(6):472–480. doi:10.1016/j.ajps.2015.07.004.